Artificial Intelligence (AI) is reshaping pharmacovigilance, promising faster detection of safety signals hidden within ...

California biotech Unnatural Products (UNP) announced a strategic multi-target research collaboration with Dutch immunology ...

US biotech IGM Biosciences yesterday revealed it has entered into a definitive merger agreement to be acquired by Concentra ...

Swiss biosimilars and generics major Sandoz has announced the start of construction for a new, state-of-the-art biosimilars ...

Mental health company atai Life Sciences (NASDAQ: ATAI) was trading more than 31% higher during Tuesday morning’s trading in ...

Sino-American antibody company Adagene (Nasdaq: ADAG) has announced a strategic investment and option exercise by Sanofi ...

A Republican-backed amendment to the sweeping budget proposal championed by US president Donald Trump would sharply reduce ...

Vertex Pharmaceuticals today announced that the European Commission has granted approval for Alyftrek ...

Marking a new step forward in its international growth, Spanish privately-held pharma company Esteve has entered into an ...

The US Food and Drug Administration (FDA) has issued a complete response letter (CRL) for Unicycive Therapeutics’ New Drug ...

Swedish biotech Camurus (Nasdaq Stockholm: CAMX) has secured EU marketing authorization for its once-monthly acromegaly ...

The US Food and Drug Administration (FDA) is revising the labeling of all extended-release stimulants indicated to treat attention-deficit/hyperactivity disorder (ADHD)—including certain formulations ...